Mineralocorticoid Receptor Antagonists(MRAs)

DRUG2 trials

Sponsors

Nanfang Li, University of Pennsylvania

Conditions

Diabetes Mellitus, Type 2Diabetic NephropathiesHyperaldosteronaemiaHypertensionKidney DiseasesRenal Insufficiency, Chronic

Phase 4

Effect of MRA on Cardiovascular Disease in Patients With Hypertension and Hyperaldosteronemia

Enrolling by invitationNCT05688579

Nanfang LiHyperaldosteronaemia, Hypertension

Start: 2023-04-16End: 2026-12-31Target: 8000Updated: 2023-04-18

Unknown Phase

Transformative Research in Diabetic Nephropathy 2.0

RecruitingNCT07444203

University of PennsylvaniaDiabetes Mellitus, Type 2, Diabetic Nephropathies, Kidney Diseases +1

Start: 2025-11-12End: 2028-11-12Target: 200Updated: 2026-03-02